Your search returned 3 results.

Results
	1.	Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. [Review] MedStar authors: Groninger, Hunter PMID: 26718105 Year: 2016 Citation: Nature Reviews Clinical Oncology. 13(4):209-27, 2016 Apr. Institution: MedStar Washington Hospital Center Department: Medicine/Palliative Care Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gharwan H, Groninger H DOI: http://dx.doi.org/10.1038/nrclinonc.2015.213 Add to cart (remove)
	2.	The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors: Swain, Sandra M PMID: 26759246 Year: 2016 Citation: Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D Add to cart (remove)
	3.	Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report. MedStar authors: Cardis, Michael A PMID: 31164102 Year: 2019 Citation: BMC Cancer. 19(1):539, 2019 Jun 04. Institution: MedStar Washington Hospital Center Department: Dermatology Medline publication type: Journal Article Form of publication: Journal Article All authors: Brownell I, Cardis MA, Gulley JL, Jiang H, Strauss J DOI: https://dx.doi.org/10.1186/s12885-019-5759-1 Add to cart (remove)

Powered by Koha